Published April, 2026
By Vyacheslav Lyubchich, K. Halimeda Kilbourne, Nathaniel K. Newlands, Adam B. Smith, Yulia Gel and Thomas James Miller
Publisher: Taylor & Francis (CRC Press)
Rating: 1.00
Availability: Available

Presents the topic of assessing and quantifying the climate change and its impacts from a multi-faceted perspective of ecosystem, human health, and social and infrastructure resilience, given through a lens of statistical and data sciences.

---

Published January, 2026
By Bendix Carstensen
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available

---

Published January, 2026
By Mona Kanaan, David J Torgerson, Ada Keding, Noreen Mdege, Jessica Kasza and Karla Hemming
Publisher: Taylor & Francis (CRC Press)
Rating: 1.00
Availability: Available

---

Published December, 2024
By Mark Wilson and Paulus de Boeck
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available

---

Published December, 2024
By Alison Cottell
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available

---

Published December, 2024
By Douglas Landsittel
Publisher: Elsevier (Apple Academic Press Inc.)
Rating: 2.00
Availability: Available

---

Published June, 2024
By Kishore Chaudhry, Sharang Chaudhry and Prashanti Bollu
Publisher: Elsevier (Academic Press Inc)
Rating: 1.00
Availability: Available

---

Published March, 2024
By Ming Tan, Hongbin Fang, Douglas Ross and M Tan
Publisher: John Wiley & Sons Ltd (John Wiley & Sons Inc)
Rating: 1.00
Availability: Available

Containing the historical and statistical information necessary to choose an analysis method and successful drug combination, Evaluating Synergy provides a systematic introduction of statistical methods for optimally designing and analyzing combination studies in cancer, anti-viral, and other therapeutic areas.

---

Published March, 2024
By Tze Leung Lai and Philip Lavori
Publisher: Taylor & Francis (CRC Press Inc)
Rating: 1.00
Availability: Available

This book focuses on current research and methodologies developed for re-engineering cancer clinical trials and also for "hot" areas in drug development trials such as adaptive design, seamless Phase 2-3 trials, and personalized medicine using biomarkers. Background statistical methodology is summarized in the Appendix.

---

Published February, 2024
By Gene Garrard Olinger, Jr.
Publisher: Taylor & Francis (CRC Press)
Rating: 2.00
Availability: Available

This book recounts the Ebola Virus Outbreak of 2014-2015 by merging clinical and diagnostic issues with behavioral and political factors. Lessons learned are intended to help future respondents by improving coordination and collaboration. This is a case study of failures and successes highlighted by the struggle to halt this devastating epidemic.

---